Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Saved in:
Bibliographic Details
Title: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.
Authors: Patel, Mira A.1, Kim, Jennifer E.1, Theodros, Debebe1, Tam, Ada2, Velarde, Esteban3, Kochel, Christina M.2, Francica, Brian2, Nirschl, Thomas R.2, Ghasemzadeh, Ali2, Mathios, Dimitrios4, Harris-Bookman, Sarah4, Jackson, Christopher C.4, Jackson, Christina4, Xiaobu Ye4, Tran, Phuoc T.2,3,5, Tyler, Betty4, Coric, Vladimir6, Selby, Mark6, Brem, Henry1,4, Drake, Charles G.5
Source: Journal for ImmunoTherapy of Cancer. 5/17/2016, Vol. 4, p1-13. 13p.
Database: Academic Search Ultimate
Description
ISSN:20511426
DOI:10.1186/s40425-016-0132-2